18^th World Congress on Endocrinology & Diabetes November 22-23, 2022 Amsterdam, Netherlands

Vladimír Štrbák has worked at the Institute of Experimental Endocrinology, Slovak Academy of Sciences. He was Organizer and chairman of the five International symposia on Hormones in Milk, resident of the International Symposium on Cell volume and function 1997. He was Organizer and chairman Symposium Cell Volume, physiological and pathophysiological aspects, 5th International Congress of Pathophysiology, June 28-July 1, 2006, Beijing, China, published in Chinese Journal of Pathophysiology, June 2006, Volume 22, No 13, Supplement p. 167. Organizer and chairman of the session Cell Volume Regulation and Cell Functions The Physiology of Anion Transport and Cell Volume Regulation (August 3-6, 2009, Okazaki, Japan) Symposium following the IUPS Congres (Kyoto). Most important activities in last three years: 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, Dubai, UAE, Organizing Committee Member, Keynote speaker. 13th Global Diabetes Conference and Medicare Expo, August 8-10, 2016, Birmingham, UK, Organizing Committee Member, Keynote speaker. 16th Global Diabetes Conference and Medicare Expo, March 22-23,2017 Rome, Italy, Organizing Committee Member, Keynote speaker, Chair of the Session. 15th World Congress on Endocrinology and Diabetes, September 20-21, 2019, Prague, Czech Republic, Organizing Committee member, Keynote speaker, Chair of the Session.

Endocrinology, Diabetes and Pathophysiology

Ravi Muppirala is a Biophysicist who has held academic appointments at T.I.F.R., Carnegie-Mellon, Syracuse University, and the University of Michigan. His expertise and interests span NMR, bio-molecular structure-dynamics, origins of primitive cells, and type-2 diabetes. His current research interests include targeting the root causes of type2 and new therapeutics towards pulsatile endogenous insulin secretion.

Type-2 diabetes, NMR, bio-molecular structure-dynamics and pulsatile endogenous insulin secretion

Eduardo J. Simoes MD, MSc, MPH completed his medical degree from Faculdade de Medicina, Universidade de Pernambuco (Brazil) in 1981, Master of Science in Community Health and Diploma of Hygiene and Tropical Medicine from the London School of Hygiene and Tropical Medicine, University of London (England) in 1987, and Master of Public Health from Emory School of Public Health, Emory University (United States) in 1991. He is the chair, Dr. Stuart Wesbury distinguished professor, and HMI Alumni distinguished professor of the Department of Health Management and Informatics of the University Of Missouri School Of Medicine (since September 27, 2011). He served as primary care physician, health district planner, and director of three Primary Healthcare Clinics in the City of Recife Secretariat of Health (1980-1989). He was a visiting associate with the Centers for Diseases Control and Prevention (1991-1993), associate researcher of Emory University School of Medicine (1994), medical and state epidemiologist with the Missouri Department of Health (1995-2003). He was director of the Prevention Research Centers Program Office of the Centers for Disease Control and Prevention (February 2003- September 2011), assistant, and adjunct professor of Saint Louis University School of Public Health (1995-2011). His research work includes etiological studies, public health practice research, and evaluation of population-based interventions. His public health work includes the development of disease prevention and health promotion programs, surveillance systems, and evaluation of public health interventions. Dr. Simoes has 136 publications in peer-reviewed journals, 13 book chapters, and over 150 presentations in national and international conferences. He is a fellow of the American College of Epidemiology, a member of the Society for Epidemiological Research, and the American College of Healthcare Executives. He serves as an editorial board member of scientific journals of repute and consultant of many international and national health organizations.

Health Management and Informatics, Epidemiology, Disease Control and Prevention, public health practice research, etiological studies, and evaluation of population-based interventions

Francesco Lippi is Graduated in Medicine and Surgery at the University of Pisa, Albo Pisa 1879/79. Specialization in Endocrinology at the University of Pisa July 1982. Specialization in Nuclear Medicine at the University of Florence July 1987. He has taught at the Institute of Clinical Methodology and the Institute of Endocrinology of the University of Pisa. From 1990 as a Professor of Endocrinology at the University Hospital of Pisa. He conducted the study (page se III) on the effects of recombinant human TSH (rhTSH) adjuvant therapy in a compassionate use program for patients with differentiated thyroid carcinoma. Then used a low activity of radioiodine therapy for the treatment of thyroid remnants after surgery using rhTSH therapy without withdrawal l-thyroxine. After the Chernobyl accident participate in the European Commission Study for diagnosis and treatment of children exposed to radiations or radioactive follow-out (1990-1995). He held master's and refresher courses in Endocrinology and Nuclear Medicine at Stanford University (USA) for the treatment of thyroid carcinoma with rhTSH. He held an updated master's degree at the Mayo Clinic in Rochester (USA). Associate of scientific associations in the field of Endocrinology as Endocrine Society, American Thyroid Association, European Thyroid Association, and Medical Endocrinologist Association (AME).

Endocrinology, Nuclear Medicine, thyroid carcinoma

The Medical doctor obtained his Ph.D. from the Catholic University of Louvain / Brussels/ Belgium in 1986. Worked as researcher and university professor for about 17 years in Rudolf Magnus Institute for Neurosciences in Medical college of University of Utrecht/ Holland. Head of Department of Physiology in the Arabian Gulf University for 6 years. Author of more than 60 scientific original papers

Diabetes Mellitus, Neurosciences and Physiology

Irina Gette has completed her Ph.D. at the age of 35 years from Ural State Medical Academy. She is a senior researcher at the Ural Federal University, and a senior researcher at the Institute of Immunology and Physiology. She has published more than 50 papers in reputed journals.

Type 1 and type 2 diabetes mellitus, Immunology, and Physiology.

Joseph Fomusi Ndisang is an Associate Professor at the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 200-2005. He received a Ph.D. in Pharmacology & Toxicology from the University of Florence, Italy, in 2000. He received a Doctor of Pharmacy degree from the University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including Fellow of the American Heart Association (FAHA) in 2011; Fellow of the International College of Angiology (FICA) in 2007; Young Investigator Award by International College of Angiology (2007); Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics- Division for Drug Discovery, Development & Regulatory Affairs (2005); Young Investigator Award by the Society of Experimental Biology and Medicine (2005); Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). He has published 36 manuscripts, 57 abstracts, 2 book chapters, 1 book and has served as peer-reviewer for many highly reputed journals and funding agencies in the United States, United Kingdom, and Canada and has also served as external Ph.D. examiner in Canada and internationally. Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 64-full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as an external Ph.D. examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals and granting agencies in the United States, United Kingdom, Canada, New Zealand, and Poland.

Heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity

Dr. Ellahham is currently Cleveland Clinic Caregiver, Cleveland, US seconded as Senior Cardiovascular Consultant and Quality Advisor in Cleveland Clinic Abu Dhabi. Dr. Ellahham received his undergraduate degree in biology and his M.D. from the American University of Beirut, Beirut, Lebanon. Dr Ellahham finished his internal medicine residency in Georgetown University Hospital - Washington Hospital Center and his fellowship in Cardiology at the Virginia Commonwealth University Health System in USA.Dr. Ellahham worked in Washington DC in Georgetown University Hospital - Washington Hospital Center and in several clinical and leadership positions before moving to UAE in 2008. Dr. Ellahham continues to be an active clinician. He demonstrates great skill and experience in the management of patients with heart failure, ischemic heart disease, and valvular heart disease and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engages local and regional referring providers. He can work in a highly matrixed environment, possess strong leadership and organizational skills, and have the experience to work effectively in a large health system. He led the First AHA GWTG Heart Failure Initiative outside the US and was the recipient of the AHA GWTG Award in Wash. DC. He is the champion of the AHA GWTG in the region.

Heart and Diabetes, Six Sigma, change management, innovation, safety, outcomes research, risk management, safe surgery, genetics, cardiac imaging, sports and nutrition

Dr. Christian Dani, Ph.D., is an expert in human adipose-derived stem cells and the differentiation of pluripotent stem cells into adipocytes. He did a Ph.D. in molecular biology at Montpellier University (France). Then, he conducted 2-year program research on the biology of embryonic stem cells in Pr. A. Smith’s laboratory (Edinburgh, Scotland). He is now director of research at the French National Institute for Health and Medical Research (INSERM) and the director of the “Stem Cells and Differentiation” laboratory at the University of Nice-Sophia Antipolis.

Diabetes, Stem Cells,etc

Wei-Chiang Shen is a Professor in Pharmaceutical Sciences at the University Of Southern California School Of Pharmacy. His research interests focus on the development of novel systems for improving peptide and protein drug delivery. He has published more than 150 papers in different areas of biomedical sciences. He is a Co-Author of the textbook “Immunology” for Pharmacy Students and a Co-editor of the book “Antibody-Drug Conjugates – the 21st Century Magic Bullets for Cancer”. He was elected to Fellow of the American Association of Pharmaceutical Scientists in 1992 and Fellow of the American Association for the Advancement of Sciences in 2000

Cancer Treatment, Membranes & Transport, Protein Chemistry/Enzymology, Drug Design, Delivery